Mutator Phenotype May Be Required for Multistage Carcinogenesis

Cancer Research

Volumn 51, Issue 12, 1991, Pages 3075-3079

  Loeb, Lawrence A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; HUMAN; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMAL; HUMAN; MUTATION; NEOPLASMS; ONCOGENES; PHENOTYPE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025773554     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Foulds, L. The experimental study of tumor progression: a review. Cancer Res., 14: 317–339, 1954.
2. Nowell, P. C. The clonal evolution of tumor cell populations. Science (Washington DC), 194: 23–28, 1976.
3. Pitot, H. C., Goldsworthy, T., and Moran, S. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer. J. Supramol. Struct. Cell. Biochem., 17: 133–146, 1981.
4. Weinstein, I. B. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Cancer Res., 48: 4135–4143, 1988.
5. Balaban, G. B., Herlyn, M., Clark, W. H., Jr., and Nowell, P. C. Karyotypic evolution in human malignant melanoma. Cancer Genet. Cytogenet., 19: 113–122, 1986.
6. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smitts, A. M. M., and Bos, J. L. Genetic alterations during colorectal-tumor development. N. Engl. J. Med., 319: 525–532, 1988.
7. James, C. D., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjold, M., Collins, V. P., and Cavenee, W. K. Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48: 5546–5551, 1988.
8. Rabinovitch, P. S., Reid, B. J., Haggitt, R. C., Norwood, T. H., and Rubin, C. E. Progression to cancer in Barrett’s esophagus is associated with genomic instability. Lab. Invest., 60: 65–71, 1988.
9. Naylor, S., Johnson, B., Minna, J., and Sakaguchi, A. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature (Lond.), 329: 451–454, 1987.
10. Callahan, R. Genetic alterations in primary breast cancer. Breast Cancer Res. Treat., 13: 191–203, 1989.
11. Knudson, A. G., Jr. Genetics and etiology of human cancer, Adv. Hum. Genet., 8: 1–66, 1977.
12. Sparkes, M. D., Wilson, M. G., Towner, J. W., Benedict, W., Murphee, A. L., and Yunis, J. J. Regional assignment of genes for human esterase D and retinoblastoma to chromosome bond 13q 14. Science (Washington DC), 208: 1042–1044, 1980.
13. Mikkelsen, T., and Cavenee, W. K. Suppressors of the malignant phenotype. Cell Growth Differ., 1: 201–207, 1990.
14. Sager, R. Tumor suppressor genes: the puzzle and the promise. Science (Washington DC), 246: 1406–1412, 1989.
15. Croce, C. M. Role of chromosome translocations in human neoplasia. Cell, 49: 155–156, 1987.
16. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 159–167, 1990.
17. Armitage, P., and Doll, R. The age distribution of cancer and a multi- stage theory of carcinogenesis. Br. J. Cancer, 8: 1–12, 1954.
18. Ames, B. N., Saul, R. L., Schwiers, E., Adelman, R., and Cathcart, R. Oxidative DNA damage as related to cancer and aging: the assay of thymine glycol, and hydroxymethyluracil in human and rat urine. In: L. S. Birbaum and R. G. Cutler (eds.), Molecular Biology of Aging: Gene Stability and Gene Expression. New York: Raven Press, 1985.
19. Moolgavkar, S. H., and Knudson, A. G. Mutation and cancer: a model for human carcinogenesis. J. Natl. Cancer Inst., 66: 1037–1051, 1981.
20. Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., and Vogelstein, B. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol., 10: 5772–5781, 1990.
21. Nalbantoglu, J., Phear, G., and Meuth, M. DNA sequence analysis of spontaneous mutations at the aprt locus of hamster cells. Mol. Cell. Biol., 7: 1445–1449, 1987.
22. de Jong, P. J., Gorsovsky, A. J., and Glickman, B. W. Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: an analysis at the DNA sequence level. Proc. Natl. Acad. Sci. USA, 85: 3499–3503, 1988.
23. Peto, R. In: H. H. Hiatt, J. D. Watson, and J. A. Winsten (eds.), The Origins of Human Cancer: Cold Spring Harbor Symposium on Cell Proliferation, Vol. 4. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1977.
24. McAlister, I., Wolf, N. S., Pietrzyk, M., Rabinovitch, P. S., Priestly G., and Jaeger, B. Transplantation of hematopoietic stem cells obtained by a combined dye method fractionation of murine bone marrow. Blood, 75: 1240–1246, 1990.
25. Bertoncello, I., Bartelmez, S. H., Bradley, T. R., Stanley, E. R., Harris, R. A., Sandrin, M. S., Kriegler, B., McNiece, I. K., Hunter, S. D., and Hodgson, G. S. Isolation and analysis of primitive hemopoietic progenitor cells on the basis of differential expression of Qa-m7 antigen. J. Immunol., 136: 3219–3224, 1986.
26. McNiece, I. K., Stewart, F. M., Deacon, D. M., Temeles, D. S., Zsebo, K. M., Clark, S. C., and Quesenberry, P. J. Detection of a human CFC with a high proliferative potential. Blood, 74: 609–612, 1989.
27. Wu, C.-I., and Li, W.-H. Evidence for higher rates of nucleotide substitution in rodents than in man. Proc. Natl. Acad. Sci. USA, 82: 1741–1745, 1985.
28. Mohrenweiser, H. W., and Jones, I. M. Review of the molecular characteristics of gene mutations of the germline and somatic cells of the human. Mutat. Res., 231: 87–108, 1990.
29. Albertini, R. J., Nicklas, J. A., O’Neill, J. P., and Robison, S. H. In vivo somatic mutations in humans: measurement and analysis. Annu. Rev. Genet., 24: 305–326, 1990.
30. Bohr, V. A., and Okumoto, D. S. Analysis of frequency of pyrimidine dimers in specific genomic sequences. In: E. C. Friedberg and P. C. Hanawalt (eds.), DNA Repair: A Laboratory Manual, Vol. 3, pp 347–366. New York: Marcel Dekker, Inc., 1988.
31. Bohr, V. A., Phillips, D. H., and Hanwalt, P. C. Heterogeneous DNA damage and repair in the mammalian genome. Cancer Res., 47: 6426–6436, 1987.
32. Oiler, A. R., Rastogi, P., Morgenthaler, S., and Thilly, W. G. A statistical model to estimate variance in long term-low dose mutation assays: testing of the model in a human lymphoblastoid mutation assay. Mutat. Res., 216: 149–161, 1989.
33. Monnat, R. J., Jr. Molecular analysis of spontaneous hypoxanthine phosphoribosyltransferase, mutations in thioguanine-resistant HL-60 human leukemia cells. Cancer Res., 49: 81–87, 1989.
34. Fukuchi, K., Martin, G. M., and Monnat, R. J., Jr. Mutator phenotype of Werner syndrome is characterized by extensive deletions. Proc. Natl. Acad. Sci. USA, 86: 5893–5897, 1989.
35. Seshadri, R. Kutlaca, R. J., Trainor, K., Matthews, C., and Morley, A. A. Mutation rate of normal and malignant human lymphocytes. Cancer Res., 47: 407–409, 1987.
36. DeMars, R., and Held, K. R. The spontaneous azaguanine-resistant mutants of diploid human fibroblasts. Humangenetik, 16: 87–110, 1972.
37. Chu, E. H. Y., Boehnke, M., Hanash, S. M., Kuick, R. D., Lamb, B. J., Neel, J. V., Niezgoda, W., Pivirotto, S., and Sundling, G. Estimation of mutation rates based on the analysis of polypeptide constituents of cultured human lymphoblastoid cells. Genetics, 119: 693–703, 1988.
38. Meuth, M. The structure of mutation in mammalian cells. Biochim. Biophys. Acta, 1032: 1–17, 1990.
39. Neel, J. V., Satoh, C., Goriki, K., Fujita, M., Takahashi, N., Asakawa, J., and Hazama, R. The rate with which spontaneous mutation alters the electrophoretic mobility of polypeptides. Proc. Natl. Acad. Sci. USA, 83: 389–393, 1986.
40. Nute, P. E., and Stamatoyannopoulous, G. Estimates of mutation rates per nucleotide in man, based on observations of de novo hemoglobin mutants. In: E. Hook and I. Porter (eds.), Population and Biological Aspects of Human Mutation, pp. 337–347. New York: Academic Press, 1984.
41. Fialkow, P. J. The origin and development of human tumors studied with cell markers. N. Engl. J. Med., 291: 26–35, 1974.
42. Wainscoat, J. S., and Fey, M. F. Assessment of clonality in human tumors: a review. Cancer Res., 50: 1355–1360, 1990.
43. Duesberg, P. H. Cancer genes: rare recombinants instead of activated oncogenes. Proc. Natl. Acad. Sci. USA, 84: 2117–2124, 1987.
44. Loeb, L. A. Endogenous carcinogenesis: molecular oncology into the twenty-first century—Presidential Address. Cancer Res., 49: 5498–5499, 1989.
45. Coulondre, C., and Miller, J. H. Genetic studies of the lac repressor. III. Additional correlation of mutational sites with specific amino acid residues. J. Mol. Biol., 117: 525–567, 1977.
46. Barbacid, M. ras genes. Annu. Rev. Biochem., 56: 779–827, 1987.
47. Albertini, R. J., O’Neill, J. P., Nicklas, J. A., Heintz, N. H., and Kelleher, P. C. Alterations of the aprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes. Nature (Lond.), 316: 369–371, 1985.
48. Kaden, D. A., Bardwell, L., Newmark, P., Anisowicz, A., Skopek, T. R., and Sager, R. High frequency of large spontaneous deletions of DNA in tumor-derived CHEF cells. Proc. Natl. Acad. Sci. USA, 86: 2306–2310, 1989.
49. Wright, J. A., Smith, H. S., Watt, F. M., Hancock, M. C., Hudson, D. L., and Stark, G. R. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. USA, 87: 1791–1795, 1990.
50. Tlsty, T. D. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. USA, 87: 3132–3136, 1990.
51. Loeb, L. A., Springgate, C. F., and Battula, N. Errors in DNA replication as a basis of malignant changes. Cancer Res., 34: 2311–2321, 1974.
52. Elmore, E., Kakunaga, T., and Barrett, J. C. Comparison of spontaneous mutation rates of normal and chemically transformed human skin fibroblasts. Cancer Res., 43: 1650–1655, 1983.
53. Goldberg, S., and Defendi, V. Increased mutation rates in doubly viral transformed Chinese hamster cells. Somat. Cell Genet., 5: 887–895, 1979.
54. Cifone, M. A., and Fidler, I. J. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc. Natl. Acad. Sci. USA, 78: 6949–6952, 1981.
55. Yamashina, K., and Heppner, G. H. Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor. Cancer Res., 45: 4015–4019, 1985.
56. Springgate, C. F., and Loeb, L. A. Mutagenic DNA polymerase in human leukemic cells. Proc. Natl. Acad. Sci. USA, 70: 245–249, 1973.
57. Chan, J. Y. H., and Becker, F. F. Decreased fidelity of DNA polymerase activity during N-2-fluorenylacetamide hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA, 76: 814–818, 1979.
58. Fry, M., and Loeb, L. A. Animal Cell DNA Polymerases. Boca Raton, FL: CRC Press, Inc., 1986.
59. Kunkel, T. A., and Loeb, L. A. Fidelity of mammalian DNA polymerases. Science (Washington DC), 213: 765–767, 1981.
60. Lu, A. L., Clark, S., and Modrich, P. Methyl-directed repair of DNA base-pair mismatches in vitro. Proc. Natl. Acad. Sci. USA, 80: 4639–4643, 1983.
61. Schaaper, R. M., and Dunn, R. L. Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: the nature of in vivo DNA replication errors. Proc. Natl. Acad. Sci. USA, 84: 6220–6224, 1987.
62. Friedberg, E. C. DNA Repair. San Francisco: W. H. Freeman and Company, 1985.
63. Hartwell, L. H., and Weinert, T. A. Checkpoints: controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629–634, 1989.